Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 19.9526 | uM | 4 | 312.50 | 138.79 | 1924.00 | 296.50 | 6.4890 | 10.0324 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 326.00 | 296.50 | 1.0995 | 1.1809 | |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 312.50 | 138.79 | 121.00 | 296.50 | 0.4081 | -0.1177 |
| BT-20 | Etoposide | 0.0033113 | uM | 4 | 312.50 | 138.79 | 330.00 | 296.50 | 1.1130 | 1.2054 |
| BT-20 | PLX-4720 | 19.9526 | uM | 4 | 312.50 | 138.79 | 229.00 | 296.50 | 0.7723 | 0.5797 |
| BT-20 | Etoposide | 3.1623 | uM | 4 | 312.50 | 138.79 | 169.00 | 296.50 | 0.5700 | 0.1970 |
| BT-20 | NVP-TAE684 | 10 | uM | 4 | 312.50 | 138.79 | 91.00 | 296.50 | 0.3069 | -0.3199 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 269.00 | 296.50 | 0.9073 | 0.8299 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 221.00 | 296.50 | 0.7454 | 0.5293 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 529.00 | 848.50 | 0.6235 | 0.4770 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 584.00 | 848.50 | 0.6883 | 0.5738 | |
| BT-20 | Etoposide | 10 | uM | 4 | 625.00 | 288.04 | 285.00 | 848.50 | 0.3359 | -0.0068 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 930.00 | 848.50 | 1.0961 | 1.1212 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 986.00 | 848.50 | 1.1621 | 1.2023 | |
| BT-20 | Etoposide | 1 | uM | 4 | 625.00 | 288.04 | 606.00 | 848.50 | 0.7142 | 0.6116 |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 625.00 | 288.04 | 1030.00 | 848.50 | 1.2139 | 1.2649 |
| BT-20 | Nilotinib | 0.031623 | uM | 4 | 625.00 | 288.04 | 914.00 | 848.50 | 1.0772 | 1.0977 |
| BT-20 | Nilotinib | 3.1623 | uM | 4 | 625.00 | 288.04 | 876.00 | 848.50 | 1.0324 | 1.0413 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 4 | 625.00 | 288.04 | 1116.00 | 848.50 | 1.3153 | 1.3844 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 4 | 625.00 | 288.04 | 946.00 | 848.50 | 1.1149 | 1.1446 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 963.00 | 848.50 | 1.1349 | 1.1692 | |
| BT-20 | Etoposide | 0.1 | uM | 4 | 625.00 | 288.04 | 858.00 | 848.50 | 1.0112 | 1.0143 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 4 | 625.00 | 288.04 | 1002.00 | 848.50 | 1.1809 | 1.2252 |
| BT-20 | Nilotinib | 0.0033113 | uM | 4 | 625.00 | 288.04 | 747.00 | 848.50 | 0.8804 | 0.8430 |
| BT-20 | PLX-4720 | 0.31623 | uM | 4 | 625.00 | 288.04 | 806.00 | 848.50 | 0.9499 | 0.9351 |